Weave key facts
- Developer of an AI-enabled platform designed for generating regulatory submissions, including investigational drug applications.
- It has raised $30.1M; the latest was Early Stage VC ($20.0M) in Sep 2025.
- Notable investors include Pareto Holdings, Raptor Group, Innovation Endeavors, Ground Up Ventures, Character (VC) — 11 tracked in total.
- Status: Privately Held (backing).
Who backs Weave
11+- ·The complete investor list: 11 names
- ·Watch Weave: the Monday email on marks, rounds and moves
Weave funding rounds
No funding rounds for Weave are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Weave investors
11 investors are on record for Weave, including Pareto Holdings, Raptor Group, Innovation Endeavors and Ground Up Ventures. By type, the record holds 6 venture capital firms and 1 hedge fund.
About Weave
Developer of an AI-enabled platform designed for generating regulatory submissions, including investigational drug applications. The company's platform automates clinical note abstraction pipelines, linking multimodal datasets and accelerating the discovery of all data modalities with the help of regulatory, research, and development (R&D), and clinical teams to collaborate, organize, edit, and summarize source materials into a submission-ready IND in a day, enabling researchers to make informed decisions while developing drugs.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 30
- Website
- weave.bio/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Weave doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.